Normothermic Insufflation to Prevent Perioperative Hypothermia and Improve Quality of Recovery in Elective Colectomy Patients: Protocol for a Randomized Controlled Trial.

Autor: Ryczek E; Cedar, Cardiff and Vale University Health Board, Cardiff, United Kingdom., White J; Cedar, Cardiff and Vale University Health Board, Cardiff, United Kingdom., Poole RL; Cedar, Cardiff and Vale University Health Board, Cardiff, United Kingdom., Reeves NL; University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, United Kingdom., Torkington J; University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, United Kingdom., Carolan-Rees G; Cedar, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
Jazyk: angličtina
Zdroj: JMIR research protocols [JMIR Res Protoc] 2019 Dec 20; Vol. 8 (12), pp. e14533. Date of Electronic Publication: 2019 Dec 20.
DOI: 10.2196/14533
Abstrakt: Background: Perioperative hypothermia during laparoscopy for bowel resection is a risk factor for postoperative medical complications and surgical wound infections. Despite various warming methods used during surgery, a significant number of patients experience perioperative hypothermia. Use of dry, unwarmed insufflation carbon dioxide (CO 2 ) during laparoscopic procedures may contribute to this problem. Evidence exists that the HumiGard device, which humidifies and heats CO 2 for insufflation, can reduce the risk of perioperative hypothermia.
Objective: The aim is to determine if insufflation with warmed, humidified CO 2 using the HumiGard device, alongside standard perioperative warming techniques, can improve patient recovery, including pain, surgical site infections, complications, and the use of analgesia compared with standard care alone.
Methods: The study is a multicenter, randomized, blinded (patient, surgeon, and assessor), sham device-controlled, parallel group-controlled trial of 232 patients. The study aims to recruit patients undergoing elective laparoscopic, segmental, or total colectomy. Patients will be randomized to receive HumiGard plus standard care or standard care alone (1:1 ratio). The primary outcome is patient-reported quality of recovery, measured by the validated QoR-40 (quality of recovery) questionnaire, from baseline to postoperative day 1. Secondary outcomes include postoperative pain, the incidence of hypothermia, and the rate of postoperative complications.
Results: The information gathered during a small-scale service evaluation at a single hospital was used to inform this study protocol. Before applying for a grant for this full randomized controlled trial, the authors will conduct a feasibility study of 40 patients to ensure that the protocol is feasible and to inform our sample size calculation.
Conclusions: The randomized controlled trial is designed to provide high-quality evidence on the effectiveness of the HumiGard device in potentially reducing the risk of perioperative hypothermia in patients scheduled for laparoscopic colectomy. The results will be used to improve the maintenance of adequate patient body temperature during surgery.
International Registered Report Identifier (irrid): PRR1-10.2196/14533.
(©Edyta Ryczek, Judith White, Ruth Louise Poole, Nicola Laura Reeves, Jared Torkington, Grace Carolan-Rees. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 20.12.2019.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje